Active Ingredient History

  • Now
Carbamazepine is an analgesic, anti-epileptic agent that is FDA approved for the treatment of epilepsy, trigeminal neuralgia. It appears to act by reducing polysynaptic responses and blocking the post-tetanic potentiation. It depresses thalamic potential and bulbar and polysynaptic reflexes, including the linguomandibular reflex in cats. Commonly reported side effects of carbamazepine include: dizziness, drowsiness, nausea, ataxia, and vomiting. Carbamazepine is a potent inducer of hepatic CYP1A2, 2B6, 2C9/19, and 3A4 and may reduce plasma concentrations of concomitant medications mainly metabolized by CYP1A2, 2B6, 2C9/19, and 3A4 through induction of their metabolism, like Boceprevir, Cyclophosphamide, Aripiprazole, Tacrolimus, Temsirolimus and others.   NCATS

  • Mol. Mass: 236.2686
  • ALogP: 3.39
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)


$0.0456 - $10.0634

United States

$0.1250 - $5.3228
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

5-carbamoyl-5h-dibenz(b,f)azepine | 5-carbamoyl-5h-dibenz[b,f]azepine | 5-carbamoyl-5h-dibenzo(b,f)azepine | 5-carbamyl-5h-dibenzo(b,f)azepine | 5h-dibenz(b,f)azepine-5-carboxamide | arbil mr | carabamazepine | carbagen sr | carbamazepen | carbamazepin | carbamazepina | carbamazepine | carbamazépine | carbamazepine anhydrous | carbamazepine dihydrate | carbamazepine hydrate | carbamazepine hydrochloride | carbamazepine phosphate | carbamazepine sulfate | carbamazepine tartrate | carbamazepinum | carbamazine | carbatrol | carbazepine | carbemazepine | cbz | epimaz | epimaz ret | epitol | equetro | g-32883 | sirtal ret | tegretol | tegretol chewtab | tegretol prolonged release | tegretol xr | tegretol-xr | teril | teril ret | timonil 200 ret | timonil 400 ret


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue